C11 Sodium Acetate PET/CT Imaging of PCa

NO_LONGER_AVAILABLE

Conditions studied: Prostate Cancer

In brief

The investigators propose to conduct Carbon-11 Sodium Acetate PET/CT studies. The purpose of our study is to evaluate the impact of Carbon-11 Sodium Acetate PET/CT studies on patient management in patients with prostate cancer.

Key facts

Study ID

NCT02826395

Run by

Jonsson Comprehensive Cancer Center

Last updated by the study team

2020-07-24

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed prostate cancer
• Able to remain still for duration of each imaging procedure (about 30 minutes)

You may not qualify if…

• Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
• Any additional medical condition, serious concurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance.

Where it is running

• 200 Medical Plaza, B114 — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.